SummaryJapanese researchers have developed AUN, a groundbreaking bacterial therapy that clears tumors even in immunocompromised patients, with minimal side effects. This innovation, now heading toward clinical trials within six years, could revolutionize cancer treatment by working independently of the immune system and avoiding severe immune-related complications.